GlobeNewswire by notified

NetAlly Launches First Integrated Bluetooth/BLE Site Survey Solution with New Software for EtherScope® nXG Portable Network Analyzer

Share

Users can now conduct simultaneous active and passive Wi-Fi surveys, Bluetooth/BLE surveys, network topology discovery, and network analysis, all on a single site walkthrough

COLORADO SPRINGS, Colo., May 12, 2021 (GLOBE NEWSWIRE) -- NetAlly is announcing the availability of the EtherScope nXG v1.5 software with Bluetooth and BLE (Bluetooth Low Energy) site survey capability as part of its AirMapper™ Site Survey Ecosystem of products.

Bluetooth is the second most popular wireless technology in the world, used for many applications from indoor location services to IoT device connectivity. But to this point, there were no solutions in the market to perform location-based surveying and visual heatmapping of Bluetooth beacons. In response to this market need, NetAlly is introducing the first Bluetooth and BLE site survey solution on the market.

James Kahkoska, NetAlly CTO, says, “It’s surprising how many Bluetooth devices are already present in most environments, and with the expansion of location-based services such as way finding and asset tracking, it’s only going to increase. But deployment is a very manual process, prone to configuration errors.”

The new functionality will allow EtherScope nXG users to perform a passive Bluetooth or BLE site survey using the AirMapper app and internal radio, thus providing full visibility into Bluetooth network coverage and performance through the company’s Link-Live Cloud Service. It will also allow users to perform both Wi-Fi (active and passive) and Bluetooth surveys on the same walkthrough, making it quick and easy to validate Wi-Fi network performance while at the same time validating indoor location services or IoT deployments, as well as possible 2.4GHz Wi-Fi interference caused by Bluetooth co-existence in the same band.

“Being able to observe coverage or reach of individual beacons and quickly spot mis-provisioned beacons is a huge step forward for organizations utilizing Bluetooth technology,” says George Stefanick, Mobility Solutions Architect at Active Expert. “As a wireless consultancy, we have seen wayfinding and asset tracking expanding across healthcare. If you’ve been doing anything with Bluetooth beacon deployments, there’s been nothing out there to help in a small form factor – until now.”

The NetAlly AirMapper Site Survey app on EtherScope nXG collects data from the three main beacon types: Eddystone UID, Eddystone URL, and iBeacon. Measured RSSI data from all observed beacons is displayed in a visual heatmap in the company’s free Link-Live Cloud Service. An accompanying data table contains all location-specific details such as beacon type, RSSI, Tx power, class name, services, beacon ID numbers, and more. This data can be easily and quickly filtered, sorted, and included in reports similar to Wi-Fi surveys.

Stefanick continues, “To be able to walk a facility once, and gather all that information is an incredible time-saver. I can’t think of any other solution that provides this kind of network visibility, all in the palm of your hand.”

This software release also includes the previously announced LANBERT™ Media Qualification app and Discovery Difference Analysis in the company’s Link-Live Cloud Service.

For more information about Bluetooth/BLE surveys and the EtherScope nXG Portable Network Expert, please visit https://netally.com/airmapper-site-survey.

About NetAlly
The NetAlly®  family of network test and analysis solutions has been helping network engineers and technicians better deploy, manage, and maintain today’s complex wired and wireless networks for decades. Since creating the industry’s first handheld network analyzer in 1993, NetAlly continues to set the standard for portable network analysis. With tools that include EtherScope™ nXG, AirMagnet®, LinkRunner®, LinkSprinter®, AirCheck™, and more. NetAlly simplifies the complexities of network testing, provides instant visibility for efficient problem resolution, and enables seamless collaboration between site personnel and remote experts. To learn more and see how NetAlly helps network professionals get their jobs done fast, visit https://netally.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ec74ce6e-6f76-45fd-be66-4b3fdfbac6c6

A PDF accompanying this announcement is available at http://ml.globenewswire.com/Resource/Download/9c34989f-03dd-4899-a464-19576eabc06a

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Havila Shipping ASA: Årsrapport 202319.4.2024 17:06:25 CEST | Pressemelding

Styret i Havila Shipping ASA har i dag godkjent regnskap og årsrapport for 2023 for konsern og morselskap. Resultatregnskap og balanser er i samsvar med foreløpig regnskap offentliggjort 27. februar 2024. Kontakter: Administrerende direktør Njål Sævik, +47 909 35 722 Finansdirektør Arne Johan Dale, +47 909 87 706 Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 Vedlegg HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Havila Shipping ASA : Annual Report 202319.4.2024 17:06:25 CEST | Press release

Today, the Board of Directors of Havila Shipping ASA has approved the financial statements for 2023 for both the Group and the parent company. The accounts are in line with preliminary accounts released on 27 February 2024. Contacts: Chief Executive Officer Njål Sævik, +47 909 35 722 Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons19.4.2024 17:05:00 CEST | Press release

Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 202419.4.2024 17:00:00 CEST | Press release

Company announcement – No. 22 / 2024 Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the implementation of long-term incentive programs (the “LTIP”) for Zealand's Board of Directors, Corporate Management and employees in accordance with Zealand's remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on March 20, 2024 (“Remuneration Policy”). Long-term incentive program Zealand has made the following awards in its long-term incentive plan. It has awarded: 20,497 restricted stock units ("RSUs") to Zealand's Board of Directors 52,777 performance stock units ("PSUs") and 52,777 RSUs have been awarded to Zealand’s Corporat

Dr. Sam Barrell CBE appointed as CEO of LifeArc19.4.2024 17:00:00 CEST | Press release

PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam’s appointment follows an extensive international recruitment process. Sam will join LifeArc from the Francis Crick Institute where she is currently Deputy CEO with responsibility for strategic management and operational leadership, as well as deputising for the Director, Sir Paul Nurse. She joined the Crick in 2017 as Chief Operating Officer. Sam brings over 25 years of experience in the life science and healthcare sectors, and a wealth of knowledge of the activities in commercial, digital and health tech spaces which are critical to LifeArc’s strategy. She studied medicine, training as an anaesthetist and serving in General Practice for many years, and has held a number of senior leadership positions in the NHS, most recently as CEO of Taunton and Somerset NHS Foundation Trust. She

HiddenA line styled icon from Orion Icon Library.Eye